Schumacher, Jessica R.
Neuman, Heather B.
Chang, George J.
Kozower, Benjamin D.
Edge, Stephen B.
Yu, Menggang
Vanness, David J.
Si, Yajuan
Jacobs, Elizabeth A.
Francescatti, Amanda B.
Spears, Patricia A.
Havlena, Jeffrey
Adesoye, Taiwo
McKellar, Daniel
Winchester, David
Burnside, Elizabeth S.
Greenberg, Caprice C.
Ballman, Karla
Schrag, Deborah
Partridge, Ann
Ruddy, Kathryn
Gavin, Patrick
Green, Bettye
Perlmutter, Jane
Berger, Elizabeth
Punglia, Rinaa
Chen, Ronald
Brys, Nicole
Zhang, Ying
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01)
https://doi.org/10.1245/s10434-018-6496-4
Use of Breast Imaging After Treatment for Locoregional Breast CancerĀ (AFT-01)
https://doi.org/10.1245/s10434-018-6359-z
Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)
https://doi.org/10.1245/s10434-019-07846-2
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (CE-1304-6543)
National Institutes of Health (5K12CA087718, K12HD055894, KL2TR000136-09, UL1TR000135)
National Cancer Institute (T32CA090217, U10CA180821)
Article History
Received: 29 November 2017
First Online: 17 May 2018